Dong Song et al.
American journal of translational research, 6(3), 302-311 (2014-06-18)
Although HER2 and ER pathways are predominant pathways altered in breast cancer, it is now well accepted that many other signaling pathways are also involved in the pathogenesis of breast cancer. The understanding of these additional pathways may assist in